Cargando…

Toll-like receptor 2 polymorphism in juvenile dermatomyositis

Detalles Bibliográficos
Autores principales:	Mathiesen, P, Enevold, C, Lange, T, Kornblit, B, Nielsen, S, Müller, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194437/ http://dx.doi.org/10.1186/1546-0096-9-S1-O40

Ejemplares similares

8.3 Disease patterns in Danish Juvenile Dermatomyositis patients
por: Mathiesen, PR, et al.
Publicado: (2008)

Sub-phenotyping of juvenile dermatomyositis: can it assist clinical decisions?
por: Yasin, Shireena A, et al.
Publicado: (2014)

Innate immunity and Toll-like receptors
por: O'Neill, LAJ
Publicado: (2004)

Effectiveness of anti-TNF-α agents in the treatment of refractory juvenile dermatomyositis
por: Boulter, EL, et al.
Publicado: (2011)

A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
por: Broen, Jasper CA, et al.
Publicado: (2011)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

Toll-like receptor family: receptors essential for microbial recognition and immune responses
por: Akira, S, et al.
Publicado: (2003)

Toll like Receptors (TLRs) expression in HIV children
por: Madeshwaran, M, et al.
Publicado: (2014)

PReS-FINAL-2016: Bone mineral status in a long-term follow up of juvenile dermatomyositis patients
por: Kristensen, VA, et al.
Publicado: (2013)

PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
por: Piper, C, et al.
Publicado: (2013)

Activation of synovial fibroblasts via Toll-like receptor signaling
por: Kyburz, D, et al.
Publicado: (2003)

Toll-like receptor expression in severe asthma with chronic rhinosinusitis
por: Malmhäll, Carina, et al.
Publicado: (2013)

CD4(+)FOXP3(+) regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
por: Vercoulen, Yvonne, et al.
Publicado: (2011)

Regulation of innate and adaptive immunity and autoimmunity by Toll-like receptor 9
por: Krieg, AM
Publicado: (2004)

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
por: Ferrari, C, et al.
Publicado: (2008)

TNF dependency of IL-17-induced joint pathology can be circumvented by Toll-like receptor-2 signaling
por: Van den Berg, W, et al.
Publicado: (2003)

PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
por: Ruperto, N, et al.
Publicado: (2013)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

Activation of Toll-like receptor-2 by tumor associated matrix metalloproteinase-2 modulates dendritic cell function
por: Godefroy, Emmanuelle, et al.
Publicado: (2014)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis
por: Gunawardena, H, et al.
Publicado: (2008)

PReS-FINAL-2193: Assessment of construct validity of new measures of global disease activity, physical function and quality of life in children with juvenile dermatomyositis
por: Ferrari, C, et al.
Publicado: (2013)

4. A paraneoplastic case of dermatomyositis
por: Wilson-Morkeh, Harold, et al.
Publicado: (2019)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Toll-like receptor 4 polymorphisms and ankylosing spondylitis
por: Adam, R, et al.
Publicado: (2005)

Toll like receptor 1 polymorphisms and susceptibility to invasive candidiasis
por: Plantinga, T, et al.
Publicado: (2009)

Dyslipidemia in active juvenile dermatomyositis patients
por: Kozu, KT, et al.
Publicado: (2011)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

PReS-FINAL-2183: IL-6 amplifies toll like receptor mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases
por: Caiello, I, et al.
Publicado: (2013)

Evaluation of the cardiovascular system in patients with juvenile dermatomyositis
por: Opoka – Winiarska, Violetta, et al.
Publicado: (2011)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

PReS13-SPK-1030: Juvenile dermatomyositis
por: Quartier, P
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_66emtlmnc43qqm7qbg8f2di1ro